Migdal Insurance & Financial Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$481M Buy
28,685,422
+2,350,000
+9% +$39.4M 5.71% 3
2025
Q1
$405M Buy
26,335,422
+300,000
+1% +$4.61M 5.68% 1
2024
Q4
$574M Buy
26,035,422
+569,412
+2% +$12.5M 8.23% 1
2024
Q3
$459M Sell
25,466,010
-3,652,200
-13% -$65.8M 7.42% 1
2024
Q2
$473M Sell
29,118,210
-739,590
-2% -$12M 7.9% 1
2024
Q1
$421M Buy
29,857,800
+938,260
+3% +$13.2M 6.74% 2
2023
Q4
$302M Buy
28,919,540
+1,860,000
+7% +$19.4M 6.08% 2
2023
Q3
$276M Buy
27,059,540
+3,413,100
+14% +$34.8M 5.9% 3
2023
Q2
$178M Buy
23,646,440
+299,880
+1% +$2.26M 4.12% 6
2023
Q1
$207M Buy
23,346,560
+1,750,000
+8% +$15.5M 4.57% 6
2022
Q4
$197M Buy
21,596,560
+216,360
+1% +$1.97M 4.38% 6
2022
Q3
$173M Buy
21,380,200
+1,847,280
+9% +$14.9M 3.89% 6
2022
Q2
$147M Sell
19,532,920
-1,333,640
-6% -$10M 3.27% 8
2022
Q1
$196M Buy
20,866,560
+1,660
+0% +$15.6K 3.42% 2
2021
Q4
$167M Sell
20,864,900
-419,655
-2% -$3.36M 1.61% 13
2021
Q3
$207M Buy
21,284,555
+1,494,519
+8% +$14.6M 2.18% 9
2021
Q2
$196M Buy
19,790,036
+90
+0% +$892 2.06% 10
2021
Q1
$229M Sell
19,789,946
-5,849
-0% -$67.6K 2.3% 8
2020
Q4
$191M Buy
19,795,795
+2,309,305
+13% +$22.3M 2.26% 9
2020
Q3
$158M Sell
17,486,490
-4,386,500
-20% -$39.5M 2.19% 9
2020
Q2
$270M Sell
21,872,990
-97,964
-0.4% -$1.21M 4.38% 3
2020
Q1
$197M Buy
21,970,954
+9,249,740
+73% +$83.1M 4.58% 3
2019
Q4
$125M Buy
12,721,214
+8,250,000
+185% +$80.9M 2.4% 11
2019
Q3
$30.8M Buy
4,471,214
+993,219
+29% +$6.83M 0.64% 37
2019
Q2
$32.1M Buy
3,477,995
+50,000
+1% +$462K 0.82% 30
2019
Q1
$53.7M Buy
3,427,995
+410,260
+14% +$6.43M 1.29% 20
2018
Q4
$46.5M Buy
3,017,735
+996,310
+49% +$15.4M 1.05% 22
2018
Q3
$43.5M Sell
2,021,425
-204,632
-9% -$4.41M 0.9% 23
2018
Q2
$54.1M Sell
2,226,057
-605,088
-21% -$14.7M 1.29% 17
2018
Q1
$48.4M Sell
2,831,145
-54,000
-2% -$923K 1.14% 23
2017
Q4
$54.7M Sell
2,885,145
-3,150,499
-52% -$59.7M 1.36% 20
2017
Q3
$106M Buy
6,035,644
+259,891
+4% +$4.58M 2.52% 10
2017
Q2
$192M Buy
5,775,753
+2,221,695
+63% +$73.8M 4.36% 4
2017
Q1
$114M Sell
3,554,058
-1,010,502
-22% -$32.4M 2.73% 6
2016
Q4
$165M Buy
4,564,560
+801,106
+21% +$29M 4.2% 3
2016
Q3
$173M Sell
3,763,454
-3,703,454
-50% -$170M 4.96% 5
2016
Q2
$375M Buy
7,466,908
+3,594,209
+93% +$181M 10.36% 2
2016
Q1
$207M Sell
3,872,699
-210,000
-5% -$11.2M 6.35% 3
2015
Q4
$268M Buy
+4,082,699
New +$268M 7.64% 2